PT1697326E - Forma cristalina de composto quinolínico e processo para a sua produção - Google Patents
Forma cristalina de composto quinolínico e processo para a sua produção Download PDFInfo
- Publication number
- PT1697326E PT1697326E PT04807807T PT04807807T PT1697326E PT 1697326 E PT1697326 E PT 1697326E PT 04807807 T PT04807807 T PT 04807807T PT 04807807 T PT04807807 T PT 04807807T PT 1697326 E PT1697326 E PT 1697326E
- Authority
- PT
- Portugal
- Prior art keywords
- crystal form
- production
- quinoline compound
- stability
- drug substance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003431788 | 2003-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1697326E true PT1697326E (pt) | 2011-09-12 |
Family
ID=34736450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT04807807T PT1697326E (pt) | 2003-12-26 | 2004-12-17 | Forma cristalina de composto quinolínico e processo para a sua produção |
Country Status (22)
Country | Link |
---|---|
US (19) | US20070112024A1 (pt) |
EP (1) | EP1697326B1 (pt) |
JP (7) | JP5186108B2 (pt) |
KR (11) | KR20190083674A (pt) |
CN (2) | CN102321019B (pt) |
AT (1) | ATE518835T1 (pt) |
AU (2) | AU2004309241A1 (pt) |
CA (1) | CA2551050C (pt) |
CY (1) | CY1112464T1 (pt) |
DK (1) | DK1697326T3 (pt) |
ES (1) | ES2367172T3 (pt) |
HK (1) | HK1095328A1 (pt) |
IL (1) | IL176470A (pt) |
MX (1) | MX338019B (pt) |
NZ (1) | NZ548041A (pt) |
PL (1) | PL1697326T3 (pt) |
PT (1) | PT1697326E (pt) |
RU (1) | RU2370489C2 (pt) |
SI (1) | SI1697326T1 (pt) |
TW (1) | TWI328006B (pt) |
WO (1) | WO2005063711A1 (pt) |
ZA (1) | ZA200605658B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2513837A1 (en) | 2003-02-12 | 2004-08-26 | Paul Adriaan Van Der Schaaf | Crystalline forms of pitavastatin calcium |
TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
US7801272B2 (en) * | 2007-09-28 | 2010-09-21 | Rigaku Corporation | X-ray diffraction apparatus and X-ray diffraction method |
JP2013516459A (ja) * | 2010-01-20 | 2013-05-13 | カディラ・ヘルスケア・リミテッド | ピタバスタチン及び医薬として許容可能なそれらの塩の製造方法 |
KR101158517B1 (ko) | 2010-04-29 | 2012-06-21 | 동방에프티엘(주) | 고 순도 피타바스타틴 칼슘염 결정형 a의 제조방법 |
US9034901B2 (en) | 2010-08-25 | 2015-05-19 | Cadila Healthcare Limited | Pitavastatin calcium and process for its preparation |
EP3178812A1 (en) | 2010-11-12 | 2017-06-14 | Hetero Research Foundation | Novel polymorphs of pitavastatin calcium |
RU2452939C1 (ru) * | 2011-01-18 | 2012-06-10 | Закрытое акционерное общество "Научные приборы" | Рентгенодифракционный способ идентификации партий фармацевтической продукции |
ITMI20111475A1 (it) * | 2011-08-02 | 2013-02-03 | Dipharma Francis Srl | Forme cristalline di pitavastatina sale di calcio |
SI2751081T1 (sl) * | 2011-09-12 | 2017-05-31 | Farma Grs, D.O.O. | Polimorfna oblika kalcijevega pitavastatinata |
WO2013098773A1 (en) * | 2011-12-28 | 2013-07-04 | Dr. Reddy's Laboratories Limited | Crystalline forms of pitavastatin calcium |
KR101461841B1 (ko) | 2012-08-08 | 2014-11-13 | 코와 가부시키가이샤 | 의약 |
JPWO2014051077A1 (ja) * | 2012-09-27 | 2016-08-25 | 日産化学工業株式会社 | 高純度の含窒素複素環化合物の製造方法 |
JP2014034574A (ja) * | 2013-01-25 | 2014-02-24 | Kowa Company Ltd | 医薬 |
US9758484B2 (en) * | 2013-03-15 | 2017-09-12 | Asieris Pharmaceutical Technologies Co., Ltd. | Base addition salts of nitroxoline and uses thereof |
CN105213319A (zh) * | 2015-09-17 | 2016-01-06 | 青岛华之草医药科技有限公司 | 一种降血脂药物匹伐他汀钙组合物干混悬剂 |
JP2016222714A (ja) * | 2016-09-20 | 2016-12-28 | 興和株式会社 | 医薬 |
WO2021181360A1 (en) * | 2020-03-13 | 2021-09-16 | Cadila Healthcare Limited | Novel salts of quinolone compounds |
EP4308089A1 (en) * | 2021-03-19 | 2024-01-24 | Zydus Lifesciences Limited | A quinolone compound in solid forms and processes for the preparation thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3175944A (en) * | 1956-06-18 | 1965-03-30 | Upjohn Co | Dihydronovobiocin and derivatives thereof |
IL63968A (en) | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
GB8320521D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
JPS61171460A (ja) * | 1985-01-23 | 1986-08-02 | Dainippon Pharmaceut Co Ltd | 塩酸メクロフエノキサ−ト1型結晶の製造法 |
JP2569746B2 (ja) * | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
JP2877366B2 (ja) | 1988-08-25 | 1999-03-31 | 協和醗酵工業株式会社 | 結晶状l−アスコルビン酸−2−リン酸ナトリウム塩の製造法 |
JP3528186B2 (ja) * | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
JPH0613526A (ja) | 1992-06-25 | 1994-01-21 | Seiko Epson Corp | 半導体装置用リードフレーム及びその製造方法 |
JP2575590B2 (ja) * | 1992-07-31 | 1997-01-29 | 塩野義製薬株式会社 | トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法 |
FR2694558B1 (fr) | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant. |
DE4235133A1 (de) | 1992-10-19 | 1994-04-21 | Bayer Ag | Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid |
JP3623531B2 (ja) | 1993-06-07 | 2005-02-23 | ビーエーエスエフ アクチェンゲゼルシャフト | 結晶質l−アスコルビン酸−2−燐酸エステルマグネシウム塩の製造法 |
JP3558684B2 (ja) * | 1994-06-28 | 2004-08-25 | 塩野義製薬株式会社 | ピロリジルチオカルバペネム誘導体の乾燥方法 |
SK1402004A3 (sk) * | 2001-08-16 | 2005-01-03 | Teva Pharmaceutical Industries Ltd. | Spôsob prípravy vápenatých solí statinov |
US6835838B2 (en) * | 2002-01-28 | 2004-12-28 | Novartis Ag | Process for the manufacture of organic compounds |
PT1472228E (pt) * | 2002-01-31 | 2009-06-24 | Novartis Ag | Processo para a produção de inibidores da hmg-coa reductase |
US6869970B2 (en) * | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
AU2003231361A1 (en) * | 2002-04-17 | 2003-10-27 | Yamanouchi Pharmaceutical Co., Ltd. | Novel crystal of quinoxalinedione derivative anhydride |
CA2513837A1 (en) * | 2003-02-12 | 2004-08-26 | Paul Adriaan Van Der Schaaf | Crystalline forms of pitavastatin calcium |
TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
-
2004
- 2004-11-29 TW TW093136780A patent/TWI328006B/zh not_active IP Right Cessation
- 2004-12-17 PL PL04807807T patent/PL1697326T3/pl unknown
- 2004-12-17 DK DK04807807.5T patent/DK1697326T3/da active
- 2004-12-17 MX MX2011007418A patent/MX338019B/es unknown
- 2004-12-17 KR KR1020197019411A patent/KR20190083674A/ko not_active Application Discontinuation
- 2004-12-17 EP EP04807807A patent/EP1697326B1/en active Active
- 2004-12-17 KR KR1020207032499A patent/KR20200130510A/ko not_active Application Discontinuation
- 2004-12-17 RU RU2006127044/04A patent/RU2370489C2/ru not_active Application Discontinuation
- 2004-12-17 KR KR1020177001565A patent/KR20170010111A/ko not_active Application Discontinuation
- 2004-12-17 KR KR1020187035028A patent/KR20180132973A/ko not_active Application Discontinuation
- 2004-12-17 AT AT04807807T patent/ATE518835T1/de active
- 2004-12-17 KR KR1020067011877A patent/KR20070001910A/ko not_active Application Discontinuation
- 2004-12-17 KR KR1020137001739A patent/KR20130014643A/ko not_active Application Discontinuation
- 2004-12-17 ES ES04807807T patent/ES2367172T3/es active Active
- 2004-12-17 CN CN201110198613.7A patent/CN102321019B/zh active Active
- 2004-12-17 ZA ZA200605658A patent/ZA200605658B/en unknown
- 2004-12-17 PT PT04807807T patent/PT1697326E/pt unknown
- 2004-12-17 KR KR1020117002847A patent/KR20110017936A/ko not_active Application Discontinuation
- 2004-12-17 KR KR1020207003201A patent/KR20200015826A/ko active Application Filing
- 2004-12-17 CA CA2551050A patent/CA2551050C/en active Active
- 2004-12-17 NZ NZ548041A patent/NZ548041A/en unknown
- 2004-12-17 AU AU2004309241A patent/AU2004309241A1/en not_active Abandoned
- 2004-12-17 US US10/584,208 patent/US20070112024A1/en not_active Abandoned
- 2004-12-17 WO PCT/JP2004/019451 patent/WO2005063711A1/en active Application Filing
- 2004-12-17 KR KR1020177023135A patent/KR20170098976A/ko not_active Application Discontinuation
- 2004-12-17 KR KR1020167016139A patent/KR20160075844A/ko not_active Application Discontinuation
- 2004-12-17 JP JP2006520594A patent/JP5186108B2/ja active Active
- 2004-12-17 KR KR1020187010082A patent/KR20180040732A/ko not_active Application Discontinuation
- 2004-12-17 SI SI200431760T patent/SI1697326T1/sl unknown
- 2004-12-17 CN CNA2004800389550A patent/CN1898211A/zh active Pending
-
2006
- 2006-06-21 IL IL176470A patent/IL176470A/en active IP Right Grant
-
2007
- 2007-01-25 HK HK07100926.2A patent/HK1095328A1/xx unknown
-
2009
- 2009-03-11 US US12/401,945 patent/US20090176987A1/en not_active Abandoned
-
2010
- 2010-12-13 US US12/966,102 patent/US20110082298A1/en not_active Abandoned
-
2011
- 2011-08-18 AU AU2011213742A patent/AU2011213742C1/en active Active
- 2011-09-07 US US13/227,003 patent/US20110319624A1/en not_active Abandoned
- 2011-10-20 CY CY20111100995T patent/CY1112464T1/el unknown
- 2011-11-29 JP JP2011260984A patent/JP5267643B2/ja active Active
-
2012
- 2012-06-04 US US13/487,289 patent/US20120245200A1/en not_active Abandoned
-
2013
- 2013-03-15 US US13/832,285 patent/US20130204000A1/en not_active Abandoned
- 2013-04-05 JP JP2013079889A patent/JP2013136640A/ja not_active Withdrawn
- 2013-10-30 US US14/066,762 patent/US20140058109A1/en not_active Abandoned
-
2014
- 2014-03-21 US US14/221,372 patent/US20140206719A1/en not_active Abandoned
- 2014-08-01 JP JP2014157888A patent/JP2014205719A/ja not_active Withdrawn
-
2015
- 2015-02-18 US US14/625,046 patent/US20150158816A1/en not_active Abandoned
- 2015-11-16 JP JP2015224264A patent/JP2016029102A/ja not_active Withdrawn
-
2016
- 2016-09-15 US US15/266,095 patent/US20170226061A1/en not_active Abandoned
- 2016-11-22 JP JP2016227123A patent/JP2017061536A/ja not_active Withdrawn
-
2017
- 2017-11-15 US US15/813,422 patent/US20180072676A1/en not_active Abandoned
-
2018
- 2018-01-10 JP JP2018002103A patent/JP2018052988A/ja not_active Withdrawn
- 2018-06-19 US US16/011,870 patent/US20180297956A1/en not_active Abandoned
-
2019
- 2019-01-24 US US16/256,070 patent/US20190152916A1/en not_active Abandoned
- 2019-08-19 US US16/543,653 patent/US20190367458A1/en not_active Abandoned
-
2020
- 2020-03-16 US US16/819,317 patent/US20200216395A1/en not_active Abandoned
- 2020-11-05 US US17/090,353 patent/US20210053923A1/en not_active Abandoned
-
2022
- 2022-02-28 US US17/682,065 patent/US20220177433A1/en not_active Abandoned
-
2023
- 2023-06-14 US US18/334,683 patent/US20230322679A1/en not_active Abandoned
-
2024
- 2024-04-17 US US18/637,529 patent/US20240294476A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176470A0 (en) | Crystal form of quinoline compound and process for its production | |
BG105547A (en) | Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof | |
PL1751093T3 (pl) | Podstawione pochodne kwasu cykloheksylooctowego | |
GEP20074135B (en) | Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)- benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
MX2007005710A (es) | Sales de hidroxibenzoato de compuestos de metanicotina. | |
GB0313612D0 (en) | Organic compounds | |
NZ552328A (en) | Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions | |
MXPA03011954A (es) | Nuevos derivados de acido sulfonico. | |
MX2007007446A (es) | Procesos para la produccion de 4-aminoquinazolinas. | |
ZA200508862B (en) | Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof | |
YU24001A (sh) | Nova kristalna modifikacija torasemida | |
HK1133001A1 (en) | Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6- piperazinedione) | |
FR2864787B1 (fr) | Procede de fabrication d'une solution de chlorure de sodium et d'hypochlorurite de sodium | |
ATE486867T1 (de) | Verfahren zur herstellung von hochreinem meloxicam und meloxicam-kaliumsalz | |
TW200637856A (en) | Process for producing thiazolidinedion compound and intermediate thereof | |
GB0417063D0 (en) | Process for the preparation of optically-active compounds | |
ATE270296T1 (de) | Verfahren zur herstellung von hochkristallinem natrium cefoperazon | |
DE602005013007D1 (de) | Verfahren zur herstellung von lactonen | |
NZ589496A (en) | Processes and compounds for the preparation of normorphinans | |
AP2002002587A0 (en) | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith. | |
ATE533758T1 (de) | Verfahren zur herstellung von enantiomerenreinem esomeprazol | |
MX2022006569A (es) | Proceso para la sintesis de una 2-tioalquilpirimidina. | |
SG164282A1 (en) | Taxane derivatives functionalized at the 14-position and a process for the preparation thereof | |
MXPA04001951A (es) | Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos. | |
MY152146A (en) | Hydroxybenzoate salts of metanicotine compounds |